Notification and public disclosure of transactions by persons discharging managerial responsibilities
Hikma Pharmaceuticals PLC - Executive Incentive Plan Option Exercise and Sale
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Susan Ringdal |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction
| Acquisition of Shares pursuant to the exercise of options granted at nil-cost under the 2014 Executive Incentive Plan |
| c) | Price(s) and volume(s) | Price(s): nil Volume(s): 25,012 |
| d) | Aggregated information - Volume - Price
- Total |
25,012 nil nil |
| e) | Date of the transaction | 10 August 2023 |
| f) | Place of the transaction | Outside a trading venue |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction
| Sale of Shares |
| c) | Price(s) and volume(s) | Price(s): £22.03
Volume(s): 25,012 |
| d) | Aggregated information - Volume - Price
- Total |
25,012 £22.03 £551,208.96
|
| e) | Date of the transaction | 10 August 2023 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Helen Middlemist, Deputy Company Secretary
+44 (0) 20 7399 2760
11 August 2023
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.